Oxidative alterations and hyperlipidemia in diabetes facilitate ox-LDL formation, which, together with inhibition of the release of endothelium-derived relaxation factor (EDRF), finally leads to endothelial dysfunction, inflammation, and vascular injury [9, 54]. The gene discussed is AHSP; the disease is hyperlipidemia.